Cleared Traditional

K903333 - CREATINE KINASE TEST (CK) ITEM NUMBER 6...

K903333 is the FDA 510(k) clearance for CREATINE KINASE TEST (CK) ITEM NUMBER 6... by Em Diagnostic Systems, Inc.. It is a Class 2 Chemistry device (product code CGS) cleared through the Traditional 510(k) pathway after a 23-day FDA review.

K903333 · Em Diagnostic Systems, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1990
Decision
23d
Days
Class 2
Risk

K903333 is an FDA 510(k) clearance for the CREATINE KINASE TEST (CK) ITEM NUMBER 65411. Classified as Nad Reduction/nadh Oxidation, Cpk Or Isoenzymes (product code CGS), Class II - Special Controls.

Submitted by Em Diagnostic Systems, Inc. (Gibbstown, US). The FDA issued a Cleared decision on August 17, 1990 after a review of 23 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1215 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Em Diagnostic Systems, Inc. devices

Submission Details

510(k) Number K903333 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 25, 1990
Decision Date August 17, 1990
Days to Decision 23 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
65d faster than avg
Panel avg: 88d · This submission: 23d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CGS Nad Reduction/nadh Oxidation, Cpk Or Isoenzymes
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1215
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CGS Nad Reduction/nadh Oxidation, Cpk Or Isoenzymes

All 99
Devices cleared under the same product code (CGS) and FDA review panel - the closest regulatory comparables to K903333.
AMRESCOCREAT KINASE REAGENT 7716/17,7516,7416,7116
K904004 · Amresco, Inc. · Dec 1990
CREATINE PHOSPHOKINASE
K903775 · Amresco, Inc. · Oct 1990
REFLOTRON CREATINE KINASE TEST TABS
K904102 · Boehringer Mannheim Corp. · Sep 1990
CREATINE KINASE-MB TEST (MB-DS) ITEM #67655
K902483 · Em Diagnostic Systems, Inc. · Jul 1990
COULTER CK (CREATINE KINASE) REAGENT
K901267 · Coulter Corp. · May 1990
CREATINE KINASE FOR MANUAL/AUTOMATED APPLICATIONS
K894715 · Catachem, Inc. · Nov 1989